UBS Group AG - ICECURE MEDICAL LTD CAESAREA ownership

ICECURE MEDICAL LTD CAESAREA's ticker is and the CUSIP is M53071136. A total of 10 filers reported holding ICECURE MEDICAL LTD CAESAREA in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ICECURE MEDICAL LTD CAESAREA
ValueSharesWeighting
Q3 2023$7,986
+301.9%
14,789
+755.8%
0.00%
Q1 2023$1,987
-95.6%
1,728
-94.0%
0.00%
Q4 2022$44,928
+1397.6%
28,986
+1302.3%
0.00%
Q3 2022$3,000
-57.1%
2,067
-45.9%
0.00%
Q2 2022$7,000
-30.0%
3,824
-6.0%
0.00%
Q1 2022$10,000
+11.1%
4,069
+38.8%
0.00%
Q4 2021$9,000
-62.5%
2,931
+7.9%
0.00%
Q3 2021$24,0002,7170.00%
Other shareholders
ICECURE MEDICAL LTD CAESAREA shareholders Q2 2022
NameSharesValueWeighting ↓
BOURGEON CAPITAL MANAGEMENT LLC 2,700$6,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,000$48,0000.00%
ROYAL BANK OF CANADA 687$2,0000.00%
Bartlett & Co. LLC 250$1,0000.00%
UBS Group AG 4,069$10,0000.00%
OSAIC HOLDINGS, INC. 2,000$5,0000.00%
BANK OF AMERICA CORP /DE/ 26,914$64,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Citadel Advisors 14,404$35,0000.00%
Tower Research Capital LLC (TRC) 13$00.00%
View complete list of ICECURE MEDICAL LTD CAESAREA shareholders